Berkshire Bank Amgen Inc Transaction History

Berkshire Bank

$398 Million
Q2 2024

A detailed history of Berkshire Bank transactions in Amgen Inc stock. As of the latest transaction made, Berkshire Bank holds 1,871 shares of AMGN stock, worth $602,854. This represents 0.15% of its overall portfolio holdings.

Number of Shares

1,871

Previous 1,806 3.6%

Holding current value

$602,854

Previous $513,000 13.84%

% of portfolio

0.15%

Previous 0.13%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	BUY	$262.75 - $319.31 $17,078 - $20,755	65 Added 3.6%	1,871 $584,000
Q1 2024 Apr 24, 2024	BUY	$268.87 - $324.56 $80,661 - $97,368	300 Added 19.92%	1,806 $513,000
Q4 2023 Jan 22, 2024	SELL	$255.7 - $288.46 $53,952 - $60,865	-211 Reduced 12.29%	1,506 $433,000
Q3 2023 Nov 01, 2023	BUY	$218.65 - $271.46 $43,730 - $54,291	200 Added 13.18%	1,717 $461,000
Q2 2023 Jul 12, 2023	SELL	$214.27 - $253.37 $13,070 - $15,455	-61 Reduced 3.87%	1,517 $336,000
Q1 2023 Apr 11, 2023	SELL	$225.79 - $275.2 $79,026 - $96,320	-350 Reduced 18.15%	1,578 $381,000
Q3 2022 Nov 07, 2022	BUY	$224.46 - $253.15 $4,489 - $5,063	20 Added 1.05%	1,928 $434,000
Q2 2022 Jul 15, 2022	SELL	$230.71 - $256.74 $17,303 - $19,255	-75 Reduced 3.78%	1,908 $464,000
Q4 2021 Jan 28, 2022	SELL	$198.88 - $227.6 $3,977 - $4,552	-20 Reduced 1.0%	1,983 $446,000
Q3 2021 Oct 14, 2021	SELL	$212.27 - $248.7 $100,403 - $117,635	-473 Reduced 19.1%	2,003 $426,000
Q2 2021 Jul 26, 2021	SELL	$233.58 - $259.14 $43,679 - $48,459	-187 Reduced 7.02%	2,476 $603,000
Q1 2021 Apr 19, 2021	SELL	$221.91 - $258.6 $23,300 - $27,153	-105 Reduced 3.79%	2,663 $662,000
Q4 2020 Jan 27, 2021	SELL	$216.38 - $257.67 $362,436 - $431,597	-1,675 Reduced 37.7%	2,768 $636,000
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $1.04 Million - $1.16 Million	4,443 New	4,443 $1.13 Million

Others Institutions Holding AMGN

# of Institutions

3,055

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $172B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Berkshire Bank, based on Form 13F filings with the SEC.

News

Stay updated on Berkshire Bank with notifications on news.

Account